Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients
Clinical trial NCT01668641 · COMPLETED
Trial details
- NCT number
- NCT01668641
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2012-09-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.